Fig. 5From: Baseline soluble MICA levels act as a predictive biomarker for the efficacy of regorafenib treatment in colorectal cancerAssociation of pharmacokinetics of regorafenib or its active metabolites with efficacy of regorafenib. AUCt and AUCu values of regorafenib, M2, and M5 were analyzed between responders and non-respondersBack to article page